REDWOOD CITY, Calif., Aug. 07, 2017 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (NASDAQ:CHRS), today reviewed corporate events and reported financial results for the quarter ended June 30, 2017.
Corporate Highlights for the Second Quarter 2017 Include:
Oncology therapeutic franchise:
Corporate Highlights for the Second Quarter 2017 Include:
Oncology therapeutic franchise: